Cusatuzumab Antibody
Cusatuzumab (ARGX-110) is an enhanced human monoclonal antibody targeting CD70. It inhibits the CD70/CD27 signaling axis and mediates the elimination of CD70-positive leukemic stem cells (LSCs), as demonstrated in both in vitro studies and in vivo xenograft models. This makes it a relevant tool for oncology research, particularly in studying acute myeloid leukemia (AML) and other CD70-expressing malignancies.
Product Specifications
Product Name Alternative
JNJ4550, JNJ-4550, JNJ74494550, JNJ 74494550, ARGX110, ARGX-110
Target
Immunology/Inflammation related, Apoptosis
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
8.15 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
144.34 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Bacillus weihenstephanensis 10 kDa chaperonin (groS)
Recombinant Bacillus weihenstephanensis 10 kDa chaperonin (groS)
Recombinant Bacillus weihenstephanensis 10 kDa chaperonin (groS)
Recombinant Bacillus weihenstephanensis 10 kDa chaperonin (groS)
Recombinant Bacillus weihenstephanensis 10 kDa chaperonin (groS)